Charles River [CRL] vs Guardant Health [GH] Detailed Stock Comparison
Charles River
NYSE
Loading...
Guardant Health
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Charles River wins in 9 metrics, Guardant Health wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Charles River | Guardant Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 681.33 | -15.26 | Guardant Health |
| Price-to-Book Ratio | 2.18 | -22.08 | Guardant Health |
| Debt-to-Equity Ratio | 82.04 | -4.37 | Guardant Health |
| PEG Ratio | 14.47 | -20.01 | Guardant Health |
| EV/EBITDA | 10.44 | -18.07 | Guardant Health |
| Profit Margin (TTM) | -1.66% | -49.93% | Charles River |
| Operating Margin (TTM) | 16.67% | -45.75% | Charles River |
| EBITDA Margin (TTM) | 16.67% | N/A | N/A |
| Return on Equity | -1.81% | 312.48% | Guardant Health |
| Return on Assets (TTM) | 4.31% | -19.57% | Charles River |
| Free Cash Flow (TTM) | $501.61M | $-274.94M | Charles River |
| 1-Year Return | -25.99% | 87.00% | Guardant Health |
| Price-to-Sales Ratio (TTM) | 1.82 | 8.16 | Charles River |
| Enterprise Value | $9.97B | $7.57B | Charles River |
| EV/Revenue Ratio | 2.48 | 9.14 | Charles River |
| Gross Profit Margin (TTM) | 34.59% | 65.01% | Guardant Health |
| Revenue per Share (TTM) | $80 | $7 | Charles River |
| Earnings per Share (Diluted) | $-1.29 | $-3.35 | Charles River |
| Beta (Stock Volatility) | 1.48 | 1.44 | Guardant Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Charles River vs Guardant Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Charles River | -0.69% | -10.89% | -6.09% | 5.22% | -6.97% | -18.56% |
| Guardant Health | 7.62% | 30.93% | 6.71% | 30.11% | 22.14% | 70.70% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Charles River | -25.99% | -36.17% | -30.65% | 97.58% | 398.29% | 189.66% |
| Guardant Health | 87.00% | 0.09% | -36.54% | 85.72% | 85.72% | 85.72% |
Performance & Financial Health Analysis: Charles River vs Guardant Health
| Metric | CRL | GH |
|---|---|---|
| Market Information | ||
| Market Cap | $7.32B | $6.76B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 989,150 | 4,168,170 |
| 90 Day Avg. Volume | 877,473 | 2,645,913 |
| Last Close | $148.74 | $54.23 |
| 52 Week Range | $91.86 - $230.02 | $20.14 - $54.62 |
| % from 52W High | -35.34% | -0.71% |
| All-Time High | $460.21 (Sep 20, 2021) | $181.07 (Feb 08, 2021) |
| % from All-Time High | -67.68% | -70.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.31% |
| Quarterly Earnings Growth | -0.44% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | -0.50% |
| Operating Margin (TTM) | 0.17% | -0.46% |
| Return on Equity (TTM) | -0.02% | 3.12% |
| Debt to Equity (MRQ) | 82.04 | -4.37 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $68.14 | $-2.45 |
| Cash per Share (MRQ) | $3.72 | $4.19 |
| Operating Cash Flow (TTM) | $787.45M | $-238,546,000 |
| Levered Free Cash Flow (TTM) | $706.38M | $-131,174,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Charles River vs Guardant Health
| Metric | CRL | GH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 681.33 | -15.26 |
| Forward P/E | 14.47 | -20.01 |
| PEG Ratio | 14.47 | -20.01 |
| Price to Sales (TTM) | 1.82 | 8.16 |
| Price to Book (MRQ) | 2.18 | -22.08 |
| Market Capitalization | ||
| Market Capitalization | $7.32B | $6.76B |
| Enterprise Value | $9.97B | $7.57B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.48 | 9.14 |
| Enterprise to EBITDA | 10.44 | -18.07 |
| Risk & Other Metrics | ||
| Beta | 1.48 | 1.44 |
| Book Value per Share (MRQ) | $68.14 | $-2.45 |
Financial Statements Comparison: Charles River vs Guardant Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CRL | GH |
|---|---|---|
| Revenue/Sales | $984.17M | $203.47M |
| Cost of Goods Sold | $666.44M | $74.72M |
| Gross Profit | $317.73M | $128.75M |
| Research & Development | N/A | $88.52M |
| Operating Income (EBIT) | $74.67M | $-111.04M |
| EBITDA | $184.23M | $-83.84M |
| Pre-Tax Income | $35.98M | $-94.87M |
| Income Tax | $10.10M | $290,000 |
| Net Income (Profit) | $25.88M | $-95.16M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CRL | GH |
|---|---|---|
| Cash & Equivalents | $229.36M | $698.57M |
| Total Current Assets | $1.51B | $927.03M |
| Total Current Liabilities | $1.05B | $225.75M |
| Long-Term Debt | $2.99B | $1.28B |
| Total Shareholders Equity | $3.24B | $-250.79M |
| Retained Earnings | $1.84B | $-2.67B |
| Property, Plant & Equipment | $402.91M | $140.50M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CRL | GH |
|---|---|---|
| Operating Cash Flow | $130.09M | $-49.41M |
| Capital Expenditures | N/A | $-4.46M |
| Free Cash Flow | $112.37M | $-67.15M |
| Debt Repayment | $-149.39M | N/A |
| Common Stock Repurchase | $-353.13M | $-45.01M |
Short Interest & Institutional Ownership Analysis
| Metric | CRL | GH |
|---|---|---|
| Shares Short | 2.32M | 9.58M |
| Short Ratio | 2.86 | 4.80 |
| Short % of Float | 0.05% | 0.08% |
| Average Daily Volume (10 Day) | 989,150 | 4,168,170 |
| Average Daily Volume (90 Day) | 877,473 | 2,645,913 |
| Shares Outstanding | 51.14M | 123.99M |
| Float Shares | 48.63M | 119.55M |
| % Held by Insiders | 0.01% | 0.05% |
| % Held by Institutions | 1.13% | 0.99% |
Dividend Analysis & Yield Comparison: Charles River vs Guardant Health
| Metric | CRL | GH |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |